The clinical trial is a human medical study designed to test the safety and effectiveness of drugs, therapeutic products, and devices before they are ultimately launched in the market. Around the world, the market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science, and clinical research industries. Research centers and numerous organizations enhance clinical trials' productivity and effectiveness by advancing and managing clinical trials globally. According to our analysis, the Clinical Trials Market will reach the value of US$ 57.46 Billion by 2026.
clinical trials market After preclinical development, the investigational new drug passes through clinical phases I, II, III, and IV during the clinical trial. These phases explain pharmacokinetics, pharmacodynamics profile and side effect, which may be harmful or beneficial, adverse impact, and post-marketing surveillance. Furthermore, as per our analysis, the market is anticipated to be dominated by Phase III, with Phase I expected to behold the fastest growth. Factors Driving the Clinical Trials Industry Worldwide The significant factors propelling the market of the global clinical trials market are increasing new medical equipment demand and medicines among end-users, coupled with growing investment for research and development activities for the development of effective medications. Moreover, the increasing number of individuals suffering from chronic diseases and evolving circumstances & nature of certain types of chronic diseases are other factors anticipated to support the growth of the global clinical trials market to a significant extent. It expected that the Global Clinical Trials Market will expand, registering a CAGR of 14.13% during the forecast period, 2020-2026. By Indication The Oncology segment held the most considerable market presence in the clinical trials market in 2020. Clinical trials are acting as the key to making progress against cancer. Today, people live longer lives from successful cancer treatments that are the results of past clinical trials. Clinical trials have helped to find new ways to prevent and detect cancer. And have also improved the quality of life for people during and after treatment. According to Renub Research, the Clinical Trials Market is valued at US$ 26.00 Billion in 2020. By Study Designs - Global Clinical Trial Industry The Interventional Design segment has the most prominent presence in the market. In addition, the Interventional Design in oncology is a rapidly growing sub-speciality that aims to develop new disease-modifying treatment options beyond conventional surgical and oncological therapies in several disease settings. The evidence for interventional oncology success dominated by single-arm study reporting technical success or clinical efficacy. Clinical Trial Regions North America is a conventional clinical trial region, and because of the legal, regulatory considerations, the clinical trial market shifted to developing nations. In the United States, the Clinical trials are funded and sponsored by the National Institute of Health (NIH), government agencies, academic groups, voluntary health organizations, and industry. The Asia-Pacific is emerging as a natural choice and ultimate destination for the clinical trial industry. Asia-Pacific has become the most preferred destination for global clinical trials because of significant cost advantage and other resource advantages combined with the unique benefits served by Asia Pacific's 3 'P's— Population, Patients, and Physicians. Numerous pharmaceutical organizations and clinical research firms have started extracting the vast potential of Asia-Pacific and conducting clinical trials in Asia-Pacific on a big scale. global clinical trials market The report has also analyzed the competitive landscape of the following key players: ICON Plc, Wuxi AppTec, SGS SA, Syneos Health, and PRA Health Sciences Inc. Our research shows that there will be a notable increase in the efficiency and effectiveness of clinical trials in the coming years. Disruptions Caused Due to the Coronavirus Crisis: The COVID-19 pandemic has remarkably impacted the global market for clinical trials, as there has been a rising focus on developing new therapeutics or vaccines to curb or operate the disease. Also, COVID-19 has induced a slight shift in terms of the way clinical trials performed. Earlier, the global clinical trial space had been experiencing an increased interest in virtual/decentralized trials. The virtual/decentralized trials have also highlighted on conference agendas and magazine articles for a long time. Finally, with the COVID-19 outbreak, the trials have been forced to move to a virtual model to keep them on track during this pandemic situation. Renub Research latest report titled "Global Clinical Trial Market by Phases (1, 2, 3, 4), Indications (Autoimmune/Inflammation, Pain management, Oncology, CNS Condition Diabetes, Obesity, Cardiovascular, Others), Study design (Interventional Trial Market, Observational Trial Market, Expanded Access Trial Market), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Company (ICON Plc, Wuxi AppTec, SGS SA, Syneos Health, PRA Health Sciences Inc)" provides a detailed analysis of Clinical Trial Industry. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=clinical-trials-market-p.php Phases – Clinical Trials Market breakup from 4 viewpoints: 1. Phase 1 2. Phase 2 3. Phase 3 4. Phase 4 Indications – Clinical Trials Market breakup from 8 viewpoints: 1. Autoimmune/Inflammation 2. Pain management 3. Oncology 4. CNS Condition 5. Diabetes 6. Obesity 7. Cardiovascular 8. Others Study Designs – Clinical Trials Market breakup from 3 viewpoints: 1. Interventional Trial Market 2. Observational Trial Market 3. Expanded Access Trial Market clinical trials market share Region – Clinical Trials Market breakup from 5 viewpoints: 1. North America 2. Europe 3. Asia Pacific 4. Latin America 5. Middle East & Africa The Companies Covered have been covered from 3 viewpoints: • Overview • Recent Developments • Revenue Companies Covered: 1. ICON Plc 2. Wuxi AppTec 3. SGS SA 4. Syneos Health 5. PRA Health Sciences Inc About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research India Furniture Market Size is growing rapidly, and it is expected to be USD 37.72 Billion by 20266/15/2021
India is a place for unique and excellent creative work of furniture. The Indian furniture industry is popular in the nation and internationally because of its rich handicraft and attractive traditional art and design. The Indian Furniture market has evolved over time. It has broadened its market from chair and table to designed interiors like wardrobe or sofas. Furniture has been an essential part of an Indian household for centuries. The major part of the Indian furniture industry accounts in the unorganized sector.
In India, a wide variety of raw materials are used in the production of furniture like Wood, Plastic, Cane, Bamboo, Metal, and Others. Around the world, wood furniture contributes largest segments because of its numerous varieties of indigenous wood and imported wood. Nowadays, Bamboo woods are also becoming popular in place of plywood. Indian wood is known for its traditional and esthetic work. States like Kerala, Gujarat, Uttar Pradesh, Kashmir, and Punjab are commercial centers for their wonderful decorating, turning, and great finishing of their work. As per this research report, the India Furniture Market was US$ 17.77 Billion in 2020. These days’ customers also have the convenience to order furniture both online and offline—increase in digitization and flexibility of home delivery with customization option surging the online India furniture market. The companies like Pepper fry, Urban ladder and others are generating significant revenue through online platforms. At the same time, surging trends of online shopping are pushing the traditional furniture manufacturers, say Godrej, Nilkamal to introduce and sell their products through online medium. As anticipated, the India Furniture Industry Growth will be a double-digit CAGR of 13.37% during 2020-2026. India furniture market includes production of a wide range of furniture related to office, bedroom, kitchen, garden, school furniture and hospitals. Factors driving the Indian furniture market are growing disposable income with an increase in the economy, Expansion of the real estate and housing sector, Rising growth in the information technology and services sectors. Besides, other contributing factors are the remarkable growth of the mass media resulting in millions of middle-class Indians aiming for improved lifestyles, increasing desire for stylish homes in compact apartments. According to Renub Research, India Furniture Market Size is growing rapidly, and it is expected to be USD 37.72 Billion by the end of the year 2026. COVID-19 Pandemic Impact on India Furniture Industry The furniture market has witnessed tremendous growth in online order due to pandemic and lockdown. The COVID-19 pandemic has happened during the initial days of 2020 has changed the furniture industry on a huge scale. The supply chain disruption and the temporary ban on global trade have highly affected the countries with high dependencies on imports for their furniture needs. The COVID-19 pandemic has also conceptualized the importance of dropping the dependence on imports and improving digitalization and automation in this industry. Renub Research report titled “India Furniture Market by Industry Type (Organized, Un-Organized), by Ordering Method (Online, Offline), By Material Type (Wood, Plastic, Cane & Bamboo, Metal, Others), By End Users (Residential/Home, Office, Hospitality), By Products (Beds, Wardrobes/Storage, Sofas, Others), By Company (Nilkamal, Parin Furniture, Omfurn India, Century Plyboards India, Godrej Interio, Urban Ladder, Pepperfry)” provides a complete analysis of India Furniture Industry. Request a Free Sample Copy of the Report: https://www.renub.com/request-brochure-page.php?gturl=india-furniture-market-p.php Industry Type - Market breakup from 2 viewpoints 1 Organized 2 Un-Organized Ordering Method - Market breakup from 2 viewpoints 1 Online 2 Offline Material Type - Market breakup from 5 viewpoints 1 Wood 2 Plastic 3 Cane & Bamboo 4 Metal 5 Others End Users - Market breakup from 3 viewpoints 1 Residential/Home 2 Office 3 Hospitality Products - Market breakup from 4 viewpoints 1 Beds 2 Wardrobes/Storage 3 Sofas 4 Others All companies covered from 3 viewpoints • Overviews • Recent Developments • Revenues Company Covered in this Report 1 Nilkamal 2 Parin Furniture 3 Century Plyboards India 4 Godrej Industries About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. ://www.renub.com Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research Telemedicine uses ICTs (Information and communication technologies) to control international barriers and surge access to health care services. This technology mainly benefits rural and underserved communities in developing nations – groups traditionally suffer from a lack of benefits to health care services. ICTs have great potential to address the hurdles faced by both developed and developing nations in providing quality health care services and more cost-effective. As per our analysis, the Global Telemedicine Market projected to grow up to US$ 218.49 Billion by 2026.
Key players in the telemedicine market have experienced exponential growth during the COVID-19 pandemic compared to 2019. United States-based company SOC Telemed deals in telemedicine technology and services, stated that in 2020, the company’s revenue surged in COVID period. Teladoc Health Inc Company’s revenue also increased due to the COVID-19 pandemic. In China, companies like WeChat, TikTok, Weibo came together in the pandemic. They helped mental health professionals, health care bodies to provide safe health services online through mental health surveys and communication programmes. Today, the advancement in technology has further triggered the government to develop regulations and reimbursement policies revolving around telehealth. Thereon, developments in the telemedicine industry have made healthcare affordable and accessible to all. The market endures many opportunities to grow during the forecast period. The market is owing to the lack of access to care and rising provider adoption of telemedicine, increasing consumer demand and patient acceptance, and enhanced quality of care. Besides, the global giant COVID-19 has also been unprecedented and staggering, with telemedicine beholding an assertive demand shock over all regions between the pandemic. Further, the Tele-medicine Industry Worldwide is projected to grow with a staggering CAGR of 21.37% from 2020 to 2026. COVID-19 Impact on Telemedicine Market Globally virtual consultations are gracing the new normal: The unforeseen outbreak of the COVID-19 pandemic has brought the whole world to a halt. As hospitals are getting crowded with COVID-19 positive cases, the strain on healthcare staff is rising. Furthermore, the postponement and cancellation of surgeries, including appointments, have minimized patient volume in hospitals and clinics. In this era of adversities, telemedicine has emerged as a powerful weapon in the war against the COVID-19 pandemic. The global influence of COVID-19 has been unprecedented and tremendous, with telemedicine witnessing a positive demand shock across all regions amid the pandemic. Additionally, most virtual visit service providers are showcasing a tremendous increase in users and subscribers. According to Renub Research Telemedicine Market Size estimated to be US$ 68.36 Billion by 2020. Globally, the adoption of digital technologies and teleconsultations has become a helpful tool for addressing a health issue. Teleconsultations offer cheaper services and also lessen the work strain on healthcare professionals. This is the primary reason for increasing emphasis by government organizations on deploying digital health technologies, favouring the market’s growth rate. Moreover, with social distancing being the new normal, the demand for teleconsultations and digital health services peaked. By Modality segment, the market bifurcated in Real-Time Telemedicine and Remote Patient Monitoring. The real-time segment expected to witness lucrative growth owing to the drastic rise in the number of e-visits. The developed region such as North America has deemed the maximum revenue share in the global industry due to the continuous research and development initiatives. Furthermore, the regional markets in Europe anticipated showing a similar drift over the forecast period due to growing healthcare awareness coupled with cloud-based technologies acceptance in the country. In addition, the developing regions such as the Asia Pacific and the Middle East and Africa expected to experience favourable growth in the industry owing to rapid demand for healthcare assistance, especially in the rural areas. Also, the emerging economies in India and China are estimated to witness growth over the next eight-year period. Innovation and development towards telemedicine anticipated enhancing the growth in this region in the coming years. During the forecasted period, the telemedicine market is expected to become highly competitive as many start-ups seek opportunities in this sector. Globally the market studied is moderately consolidated, owing to a few prominent market players like CEVA, Inc., Eli Lilly and Company, Bayer AG, Merck & Co. Inc. and Teladoc Health, Inc. Furthermore, the Global Telemedicine Market will become highly competitive with the launch of various platforms and the entry of new players with massive funding. Renub Research new report titled "Global Telemedicine Market by Types (Products & Services) Application (Teleconsultation, Telepathology, Telecardiology, Telesurgery, Teleradiology, Teledermatology, Telepsychiatry, Others) Modality (Real-Time Telemedicine & Remote Patient Monitoring) End Users (Hospitals, Diagnostics Center, Ambulatory Surgical Center, Specialty Center & Others), Regions (North America, Europe, Asia-Pacifics, Latin America, Middle East & Africa) Company (CEVA Inc, Eli Lilly & Company, Bayer AG, Merck & Co.Inc, Teladoc Health, Inc)" provides a complete analysis of Telemedicine Market Industry Worldwide. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=telemedicine-market-p.php Types Outlook - Market has been covered from 2 viewpoints: 1. Products 2. Services Application Outlook - Market has been covered from 8 viewpoints: 1. Teleconsultation 2. Telepathology 3. Telecardiology 4. Telesurgery 5. Teleradiology 6. Teledermatology 7. Telepsychiatry 8. Others Modality Outlook - Market has been covered from 2 viewpoints: 1. Real Time Telemedicine 2. Remote Patient Monitoring End Users Outlook - Market has been covered from 5 viewpoints: 1. Hospital 2. Diagnostic Center 3. Ambulatory Surgical Center 4. Specialty Center 5. Others Region Outlook - Market has been covered from 5 viewpoints: 1. North America 2. Europe 3. Asia Pacific 4. Latin America 5. Middle East & Africa All companies have been covered from 3 Viewpoints • Overview • Recent Development & Strategies • Financial Insight Company Analysis 1. CEVA, Inc. 2. Eli Lilly and Company 3. Bayer AG 4. Merck & Co. Inc 5. Teladoc Health, Inc. About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research In-vitro diagnostics (IVDs) are a vital part of today’s healthcare system. It is used to diagnose, screen, scan, and assess predispositions to diseases monitoring. They are thereby contributing to the available medical information regarding a patient. Further allowing earlier and more targeted treatments, IVDs help reduce hospital stays; reduce costs and economic growth in the long run. As per the Renub Research report, the France In-Vitro Diagnostics market is expected to reach US$ 2.1 Billion by the end of the year 2026.
The Market for In-Vitro Diagnostic is a dynamic sector in the French medical market. Currently, the industry is undergoing significant changes. However, as the country struggles with the ever-increasing financial burdens of an ageing population and a comprehensive national health care system, the requirements of leveraging the cost/benefit advantages of effective diagnostics are becoming more and more visible in the industry. Another important IVD market in France is that the country’s private medical analysis laboratories merge into larger units. Usually, several private laboratories join together as a Sociétésd’ Exercise Liberal (liberal exercise company) known in France as an SEL. Within an SEL, each laboratory specializes in a specific type of analysis. Besides, the consolidating and regrouping of laboratories also lead to a rapidly shrinking number of biologists and laboratories, especially private laboratories, in the past few years. However, these changes are complex at first but could make the market more efficient in the long run. The France IVD Market Size was valued at US$ 1.9 Billion in 2020. The diagnostic tests in the country are assigned as a reimbursement percentage depending on the type of test, so the biologists in a public or a private laboratory can choose whatever brands of reagent they wish to use for a given diagnostic. However, regardless of their choices, they have reimbursed the percentage of cost predetermined for that kind of test. In general, the rates of reimbursement for France’s public health insurance are as follows: • Screenings for HIV or Hepatitis C are entirely free for all patients. • Other laboratory analyses reimbursed at 60-70 percent for most patients (private insurance will generally reimburse the remaining 30-40 percent) In the France IVD market segments, significant growth has happened in the Infectious Immunology segment in the year 2020. Other segments, Hematology, Immunochemistry, Microbiology, Bio-chemistry, and Genetic Testing have a slight decline for one year. But all these segments are expected to keep on growing in the long run. Clinical chemistry plays a crucial role in the France IVD market. The market for reagents has continued to grow in the past few years. The French IVD Industry is expected to increase marginally at a CAGR of 1.68% during 2020-2026. France being a developed region with a well-structured healthcare system has many players in the in-vitro diagnostics market. Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific and Sysmex Corporation are prime companies in the France In-Vitro Diagnostics (IVD) Market. COVID-19 Impact on IVD Market of France: In the France IVD market, Infectious disease tests, particularly for respiratory and hospital-acquired infections, are anticipated to have strong growth. Medical tests deemed non-essential, say routine health checks, bone health, hormone, will suffer the most due to postponement. More on this essential IVD tests for life-threatening conditions like cardiac, transplant, cancer, obstetrics, blood screening will be less affected. A general drop of inpatient visits to hospitals and clinics has occurred as a result of lockdown measures. Large investments in new diagnostic instruments not related to infectious disease testing will slow down as hospitals and labs prepare for the predicted economic downturn. Renub Research report titled “France In-Vitro Diagnostics (IVD) Market By Segments (Immunochemistry, Hematology, Infectious Immunology, Microbiology, Bio-chemistry, Genetic Testing), Types (Laboratory Reagents, Instruments), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)” provides a complete analysis of France In-Vitro Diagnostics (IVD) Industry. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=france-in-vitro-diagnostics-market-p.php Types - France In-Vitro Diagnostics (IVD) Market have been covered from 2 viewpoints: 1. Laboratory Reagents 2. Instruments Segments - France In-Vitro Diagnostics (IVD) Market have been covered from 6 viewpoints: 1. Immunochemistry 2. Hematology 3. Infectious Immunology 4. Microbiology 5. Bio-chemistry 6. Genetic Testing Reimbursement Policy 1. Public 2. Private & Insurance Companies have been covered from 3 viewpoints • Overview • Initiatives & Recent Developments • Sales Company Analysis 1. Roche Diagnostics 2. Abbott Diagnostics 3. Siemens Healthineers 4. Danaher Corporation 5. Thermo Fisher Scientific 6. Sysmex Corporation About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research Olive oil forms a different and tasty substitute to conventional edible oils. Considering its nutritional value and taste, olive oil is being consumed by a huge pool of the global population. It is extensively preferred for its properties to prevent heart diseases by maintaining cholesterol levels in the body. It also has moisturizing and exfoliating properties, which leads to its usage in different pharmaceuticals and cosmetics products. Olive oil offers various applications such as spray for dressing, cosmetics, and personal care, uses in foods, and medicines. Owing to these factors, there is a vast demand for Olive Oil in the Market. As per Renub Research Report, Global Olive Oil Market will be US$ 17.73 Billion by 2027.
In this report, we have covered the market of Olive oil market by type, which includes Extra Virgin Oil, Virgin Oil, and Other Olive Oil. Extra virgin olive oil is the most eminent quality olive oil utilized by a majority of health-conscious people. Based on end-user, retail and foodservice contributes the lion’s share to the total olive oil market value. Europe and Asia Pacific foodservice sector will be the leading market for olive oil producers in upcoming years. On the other side, retail has remained one of the most dynamically evolving realms that enable olive oil market players to regularly be on their toes to discern their target customers and maintain a customized approach. Olive Oil Industry globally will grow with a staggering CAGR of 11.49% from 2020-2027. European Union is the leading producer, exporter, and consumer, of olive. This is due to olive farming, one of the essential businesses in these countries due to the Mediterranean diet. Greece, Spain, and Italy are the primary producers and exporters in the region. Italy is one of the leading importer and majorly imports olives from the United States, China, Brazil, Japan, and Turkey. As per our research findings, Worldwide Olive Oil Market is expected to be more than in the next 7 years. For the year 2020 Olive Oil Market world over was US$ 8.28 Billion. Some of the market's major companies include Modi Naturals, Cargill, Inc., Bunge Limited, Conagra Brands (Bertolli®), Semapa. Market players are involved in continuous research and developments; these are key strategies adopted by the Olive Oil Market players. For example, in 2021, Modi Naturals will launch sub-brand Oleev Kitchen to enter RTC/E segments as consumers continue to remain indoors. Renub Research latest Report “Global Olive Oil Market By Type (Extra Virgin Oil, Virgin Oil, Other (Lampante, Pomace), Industry (Pharmaceuticals, Cosmetics, Cooking, Other), End-User (Food Service, Food Processing, Retail), Consumption Market (EU-27, Turkey, Morocco, Tunisia, Syrian Arab Republic, Algeria, Argentina, Lebanon, Jordan, Chile, Others), Production (EU-27, Turkey, Morocco, Tunisia, Syrian Arab Republic, Algeria, Argentina, Lebanon, Jordan, Chile, Others), Import (United States, EU-27, Brazil, Japan, Canada, China, Australia, Turkey, Russian Federation, Saudi Arabia, Others), Export (EU-27, Tunisia, Turkey, Syrian Arab Republic, Morocco, Argentina, Chile, United States, Lebanon, Jordan, Others), Company Analysis (Modi Naturals, Cargill, Inc., Bunge Limited, Conagra Brands (Bertolli®), Semapa.)" The study on Global Olive Oil Market gives an exhaustive outlook of Global Olive Oil Industry”. Request a Free Sample Copy of the Report:https://www.renub.com/request-sample-page.php?gturl=olive-oil-market-p.php Type – Global Olive Oil Market breakup from 3 viewpoints 1. Extra Virgin Oil 2. Virgin Oil 3. Other (Lampante, Pomace, etc) Industry - Global Olive Oil Market breakup from 4 viewpoints 1. Pharmaceuticals 2. Cosmetics 3. Cooking 4. Others End-User - Global Olive Oil Market breakup from 3 viewpoints 1. Food Service 2. Food Processing 3. Retail Consumption - Global Olive Oil Market & Volume breakup of 11 Countries 1. EU-27 2. Turkey 3. Morocco 4. Tunisia 5. Syrian Arab Republic 6. Algeria 7. Argentina 8. Lebanon 9. Jordan 10. Chile 11. Others Production - Global Olive Oil Volume breakup of 12 Countries 1. EU-27 2. Turkey 3. Morocco 4. Tunisia 5. Syrian 6. Arab Republic 7. Algeria 8. Argentina 9. Lebanon 10. Jordan 11. Chile 12. Others Olive Oil Import Analysis - Global Olive Oil Volume breakup of 11 Countries 1. United States 2. EU-27 3. Brazil 4. Japan 5. Canada 6. China 7. Australia 8. Turkey 9. Russian Federation 10. Saudi Arabia 11. Others Export - Global Olive Oil Volume breakup of 11 Countries 1. EU-27 2. Tunisia 3. Turkey 4. Syrian Arab Republic 5. Morocco 6. Argentina 7. Chile 8. United States 9. Lebanon 10. Jordan 11. Others All key players have been covered from 3 viewpoints 1. Overviews 2. Recent Developments 3. Revenues Company Analysis 1. Cargill, Inc 2. Modi Naturals 3. Bunge Limited 4. Conagra Brands (Bertolli®) 5. Semapa About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research Asia-Pacific’s is one of the most agile developing data centre regions in the world. The growing importance of smart technologies, IoT-powered devices, Big Data, Industry 4.0, 5G and cloud computing has led to Data Centers (DC) taking on a more prominent role in businesses in recent times in the region. The factors driving the growth of the APAC data centre market are the implementation of 5G network triggering edge data centre investments, procurement of renewable energy, installation of innovative data centre technology, and artificial intelligence enhancing liquid immersion & direct-to-chip cooling adoption. According to Renub Research, the Asia Pacific Data Centre Market is expected to grow with a double-digit CAGR of 12.91% during 2020-2027.
Data centers industry growth in India over the last few years has been considerable. Due to its fast growing economy, it has a strong potential to become a datacenter hub in the Asia Pacific region. The emergence of a new business environment, such as networking equipment, server and storage have significantly contributed towards collocation and data centre services among large enterprises and small & medium industries in India. The demand for data centers primarily identified from Banking, Financial Services and Insurance (BFSI), energy, government & defense, healthcare, manufacturing, IT &telecom and retail are massive. Besides, country-specific in China, the demand for high-performance computing infrastructure is increasing due to IoT, artificial intelligence, and big data analytics. The adoption of blade type servers in data centres set to grow in the country. The majority of data centres in China have adopted blade servers for the high-density computing environment. The APAC Data centre Industry, as per our research findings, the APAC Datacenter Market is anticipated to reach US$ 59.83 Billion by 2027. COVID-19 Impact on Datacenter Industry Additionally, the APAC data centre market share has witnessed outstanding growth since the outbreak of the COVID-19 pandemic, which has expanded the access to internet-related assistance aided by lockdowns and restrictions imposed by government agencies across the region. Colocation service providers saw a strong uptake of data centre spaces by existing customers owing to the growth in demand during the pandemic. In Japan, the data centre construction deposed no impact due to the pandemic; however, data center operators implemented stringent precautionary regulations for the safety of their employees. Hence, it expected that the market will witness a substantial spike in the announcement of new projects across APAC amidst the pandemic. Key Players Analysis The APAC data centre market has a strong presence of companies, including AT&T Inc., Equinix, Cisco, Microsoft and Google. The providers in the regions have conspired to fund millions of dollars in new facility expansion. Because of big data and technology boom tech companies are investing billions of dollars in data center infrastructure management. New trends are beginning to emerge given high data storage demand, fast speeds and power requirement. As per this research study, the Asia Pacific Data Centre Industry was US$ 25.58 Billion in 2020. Renub Research new report "Asia Pacific Data Centre Market by IT Infrastructure (Networking Equipment, Server, Storage), End Users (Large Enterprises, Small & Medium Industries), Verticals (BFSI, Energy, Government & Defense, Healthcare, Manufacturing, IT &Telecom, Retail, Others), Country (China, India, Japan, Singapore, Australia), Company (AT&T Inc., Equinix, Cisco, Microsoft, Google)" provides a detailed analysis of Datacenter Industry in APAC. Request a Free Sample Copy of the Report:https://www.renub.com/request-sample-page.php?gturl=asia-pacific-data-centre-market-p.php IT Infrastructure – Asia Pacific Data Center Market has been covered from 3 viewpoints: 1. Networking Equipment 2. Server 3. Storage End Users - Asia Pacific Data Center Market has been covered from 2 viewpoints: 1. Large Enterprises 2. Small & Medium Industries Country – Asia Pacific Data Center Market has been covered from 5 viewpoints: 1. China 2. India 3. Japan 4. Singapore 5. Australia Verticals - Asia Pacific Data Center Market has been covered from 8 viewpoints: 1. BFSI 2. Energy 3. Government & Defense 4. Healthcare 5. Manufacturing 6. IT &Telecom 7. Retail 8. others Company Insights: • Overview • Company Initiatives • Sales Analysis Company Analysis: 1. AT&T Inc. 2. Equinix 3. Cisco 4. Microsoft 5. Google About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research In-vitro diagnostics (IVD) plays a significant role in the Saudi Arabia healthcare system by providing accurate diagnosis and prognosis, thus enabling improved monitoring and treatment. Saudi Arabia represents the largest market for IVD in the GCC region. Diagnostics constitute a significant share of the total Kingdom’s healthcare spending. They are critical in medical decision-making and reducing diseases and healthcare expenditures. Saudi Arabia Health care Agenda, its vision of 2030 is to transform through diverse aspects, and one of the main areas of Vision 2030 is the healthcare sector. Ministry of Health plans and expenditure of 23 Billion SAR as new initiatives in the healthcare sector. According to the Renub Research report, Saudi Arabia In Vitro Diagnostics Market is expected to reach US$ 1,400.92 Million by 2027.
There has been stable growth in the adoption of IVD in Saudi Arabia. Growing occurrence rates of different infectious and chronic diseases show some of the market's drivers in Saudi Arabia. Some of the other factors catalysing the growth of IVD in Saudi Arabia include rising healthcare expenditures, improving healthcare infrastructure, initiatives by the government, rising awareness levels, etc. As per our research findings, Saudi Kingdom IVD Market was valued US$ 866.74 Million in 2020. Furthermore, due to the rising infectious diseases, cancer cases, and several people with diabetes in Saudi Arabia, it is believed that Saudi Arabia IVD Market will grow effortlessly in the coming years. Due to COVID-19 pandemic, all industry across the sector was impacted and so do Saudi Arabia IVD market. As per our study, this market would overcome during the forecast period. Looking forward, Renub Research expects the Saudi Arabia IVD Industry to exhibit growth with a CAGR of 7.10% during 2020-2027. By Segments – Immunochemistry is driving the Saudi Arabia IVD Market. Immunochemistry IVD devices have next-generation sequencing tests, which can help to sense genomic variation in person DNA. The growing old age population and increasing growth in the prevalence of chronic and infectious diseases are amongst the fundamental factors enhancing the growth and demand of the immunochemistry IVD market in Saudi Arabia. By Disease type – Infectious hold significant Saudi Arabia IVD Market market, which is attributable to the rising incidence of infectious diseases such as HIV, AIDS, SARS-CoV-2, tuberculosis, and pneumonia. Besides, an increase in the development of infectious disease detection assays by market players for IVD is expected to drive the segment. By End User – Government Hospitals & Laboratory holds the Largest Market. Most often, diagnostic centres collaborate with hospitals; hence, hospitals have their own diagnostic set up. Furthermore, the ongoing development of government healthcare infrastructure is anticipated to enhance the existing hospital facilities. Thus, the demand for Government Hospitals & Laboratory-based IVD tests is increasing. The market for IVD in Saudi Arabia is moderately competitive, and major players are actively present in the country, promoting high product availability in Saudi Arabia. Among the top companies operating in the In-Vitro Diagnostics in Saudi Arabia, Roche, Abbott, Siemens Healthineers, Sysmex Corporation, and Danaher Corporation has been studied thoroughly in the report. Renub Research report titled “Saudi Arabia In Vitro Diagnostics (IVD) Market, by Segments [Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT)]; by Applications (Infectious Diseases, Cardiovascular Diseases, Oncology, Diabetes and others); By End User (Government Labs & Hospitals, Private Labs & Hospitals and others) and by Companies (Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation)” provides a complete analysis of Saudi Arabia In-Vitro Diagnostics (IVD) Market. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=saudi-arabia-in-vitro-diagnostics-market-p.php Segments – Market have been covered from 8 viewpoints 1. Immunochemistry 2. Clinical Chemistry 3. Hematology 4. Hemostasis 5. Microbiology 6. Molecular Diagnostic 7. Self-Monitoring of Blood Glucose (SMBG) 8. Point of Care Testing (POCT) Disease Type - Market has been covered from 5 viewpoints: 1. Infectious Diseases 2. Cardiovascular Diseases 3. Diabetes 4. Oncology 5. Others End User - Market has been covered from 3 viewpoints: 1. Government Labs & Hospitals 2. Private Labs & Hospitals 3. Others All companies have been covered from 3 viewpoints: • Overviews • Recent Developments • Revenues Company Analysis: 1. Roche 2. Abbott 3. Siemens Healthineers 4. Sysmex Corporation 5. Danaher Corporation About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research South Korea is highly urbanized approx a quarter of its population lives in the city of Seoul. This country is a dynamic seafood market whose imports have grown exponential over the course of time. As per the Norwegian Sea food council, in the year 2019, South Korea has gone from being a peripheral seafood market to Asia’s second-largest seafood market. In Asia- Pacific’s region, South Korea is the 3rd largest economy after China and Japan. Around 20 percent of the landmass of South Korea is non-functional due to mountains. This is one of the reasons due to which Korean’s food inclination is towards seafood. South Koreans consume seafood more than any other country around the globe. According to Renub Research, Korea Seafood Market is projected to reach US$ 13.6 Billion by 2027.
In South Korea export of fishery products hit all time high in the year 2018, the most probable export countries was China and Japanese market. According to USDA, with respect to the seafood sector, the United States seafood exporters have more opportunities to export to South Korea as custom duties for fishery products have cut to zero or phased out for 3 to 10 years. As expected, South Korean consumers will take advantage of lower price resulting from cutting down of import duties for fishery products like Squid, Mackerels, Sailfin sandfish etc. According to Renub Research Seafood Market of South Korea will grow at a CAGR of 2.81% during 2020-2027. Over the time, in the Korean market, Norwegian seafood exports have surged due to skyrocketing demand on farmed salmon and mackerel earlier that was dominated by US exporters until 2015. In South Korea, sea food production is done in various types of aquaculture like adjacent water, shallow sea culture, distant waters, and inland water. Shallow water marine environment preferred aquaculture points as water area is between the shore and deeper water which is best-suited habitats for Korean seafood. The Seafood Industry in South Korea was valued at US$ 11.2 Billion in 2020. In recent years, a decrease in aquaculture and production in South Korea has led to the formation of various policies to increase aquaculture production. The government has prepared a long-term aquaculture development program by increasing cultivation areas for both profitable and unexploited species. South Korea population is increasingly being concern that affects fishing and aquaculture production due to the construction of industrial buildings in the country's southern and western coastal districts. Besides, South Korean people have high disposable income and enjoy seeking products that offers convenience due to their busy lifestyles. The growth factor to this market is the demand for pre-cooked, surging readymade, preserved food demand, and rising double-income families. COVID-19 impact on Seafood Industry According to World Health Organization (WHO) and the World Organisation for Animal Health (OIE), food itself is not responsible for the transmission of disease to people. Production & Supply • Impacted in distribution channels/supply chain/seafood value chain disruptions • Low overall seafood production • Seafood demand and supply imbalance • Lower restaurant traffic, increase retail sales (supermarkets and e-commerce deliveries) • Low demand for luxurious seafood products Consumers • Demand for seafood remained strong • Choice of the seafood formats - frozen, fresh, canned - shift in consumer preference/ready to eat, ready to cook meals • Suspension/Disruption of exports/imports • Strong domestic markets • The seafood supply chain is disturbed, and Transport restrictions affect supply chain • Consumers spending on direct channels for seafood dropped due to movement restrictions Renub Research latest report “South Korea Seafood Market & Volume by Water (Adjacent Water, Shallow Sea Aquaculture, Distant Waters), Products (Fishes, Shellfish, Crustacean), Species (Mackerels, Jack Mackerels, Red Snow Crabs, Snow Crabs, Purplish Washington Clams, Pen Shells, Horned Turban, Blue Crabs, Squids, Sailfin Sandfish, Mottled Skate, Others), Company (Seatrade, Atlantic Capes Fisheries, Inc, Atalanta Corporation, Ideal Foods Ltd, Sea Delights)" provides detailed analysis of Korea Sea Food Industry. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=south-korea-seafood-market-p.php Waters – Market & Volume breakup from 4 viewpoints • Adjacent Waters • Shallow Sea Aquaculture • Distant Waters • Inland Waters Product - Volume breakup from 3 viewpoints • Fishes • Shellfish • Crustacean Species - Volume breakup from 12 viewpoints • Mackerels • Jack mackerels • Red snow crabs • Snow crabs • Purplish Washington clams • Pen shells • Horned turban • Blue crabs • Squids • Sailfin sandfish • Mottled Skate • Others All companies have been covered from 2 Viewpoints • Overviews • Recent Developments Company Analysis • Seatrade • Atlantic Capes Fisheries, Inc • Atalanta Corporation • Ideal Foods Ltd • Sea Delights About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research The automotive market in Europe is one of the largest markets globally. The region is home to many global automobile part manufacturers. Consequently, owing to the growth of the automotive industry and the high tire replacement rate in Europe has fostered the development of the tyre market. Further, in the coming years, the tyre market in the region is proposed to register remarkable growth due to the influence of new technologies, such as electric and autonomous vehicles, an extension of tariff wars between the European countries. The changing preferences of younger generation consumers coupled with solid domestic production also tend to boom the market. According to Renub Research, Europe Tire Market is projected to be valued at US$ 67.73 Billion by 2026.
In the region, the United Kingdom and Germany have farms with more than 1,000 hectares, on mediocre, comprising 20% of the used farming area in the country. On the converse, in countries such as the Netherlands and Finland, the average size of a farm is 150 hectares. Therefore, the demand for replacement tyres is more in countries such as Germany, the United Kingdom, and France. Farm consolidation necessitates fertilizing and planting machinery to obtain sufficient and proper fertilizing of the crops in larger land structures, thereby facilitating the demand for agricultural tyres. In 2020, the European Tyre Industry was valued at US$ 46.02 Billion. Additionally, in Europe, the high consumer living standards sustained by their increasing per capita investments in a new vehicle (Car, LCV, MCV, HCV) have driven the demand for advanced and premium-quality tyres. Besides, the growing disposable income levels of the European middle-class population have significantly enhanced the need for crossover utility vehicles (CUVs) and sport utility vehicles (SUVs), whereby catalyzing the growth of the customer replacement tyre market. As per our research, Tire Market in Europe is poised to grow at a healthy CAGR of approximately 6.65% during 2020-2026. The major players operating in the European tyre market include Bridgestone Europe NV/SA, Michelin, Continental AG, Sumitomo Rubber Industries Ltd., And Yokohama Rubber Co. Ltd. Furthermore, the major companies are also forming advanced technologies to stay relevant in the market. Other competitive strategies include mergers & acquisitions. COVID-19 impact on Europe Tyre Market: The region witnessed a sharp decline across both the new vehicle and the replacement sector due to the COVID 19 outbreak. As a consequence, the market is expected to see a considerable drop in 2020. From 2021 onwards, however, the market is expected to regain its growth over time. Renub Research report titled “Europe Tyre (Tire) Market & Volume by New Vehicle (Passenger Car, Light Commercial Vehicle, Medium Commercial Vehicle, Heavy Commercial Vehicle), Replacement (Consumer, Truck & Bus, Agriculture, Motor Cycle), Region (Poland, Germany, Spain, France, United Kingdom, Italy, Netherlands, Turkey, Czech Republic, Austria, Greece), Company Analysis (Bridgestone Europe NV/SA, Michelin, Continental AG, Sumitomo Rubber Industries Ltd, Yokohama Rubber Co. Ltd.)" provides a detailed analysis of European Tire Market Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=europe-tire-market-p.php New Vehicle - Tyre Market & Volume Analysis has been covered from 4 viewpoints: 1. Passenger Car 2. Light Commercial Vehicle 3. Medium Commercial Vehicle 4. Heavy Commercial Vehicle Replacement - Tire Market & Volume Analysis has been covered from 4 viewpoints: 1. Consumer Replacement Tyre (Car, SUVs and LCV) 2. Truck & Bus Replacement Tyre 3. Agriculture Replacement Tyre 4. Motor Cycle Replacement Tyre Consumer Replacement - Tyre (Car, SUVs and LCV) Market & Volume Analysis has been covered from 8 Country: 1. Poland 2. Germany 3. Spain 4. France 5. United Kingdom 6. Italy 7. Netherlands 8. Turkey Truck & Bus Replacement - Tire Market & Volume Analysis has been covered from 8 Country: 1. Poland 2. Germany 3. Spain 4. France 5. United Kingdom 6. Italy 7. Netherlands 8. Turkey Agriculture Replacement - Tyre Market & Volume Analysis has been covered from 8 Country: 1. Poland 2. Germany 3. Spain 4. France 5. United Kingdom 6. Italy 7. Czech Republic 8. Austria Motor Cycle Replacement - Tire Market & Volume Analysis has been covered from 8 Country 1. Poland 2. Germany 3. Spain 4. France 5. United Kingdom 6. Italy 7. Netherlands 8. Greece All companies have been covered from 3 viewpoints • Overview • Initiatives & Recent Developments • Revenue Company Insights: 1. Bridgestone Europe NV/SA 2. Michelin 3. Continental AG 4. Sumitomo Rubber Industries Ltd. 5. Yokohama Rubber Co. Ltd. About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research Until the outbreak of COVID-19, the China Cinema Market had reached an unparalleled 'golden age. But the market declined in 2020 due to COVID-19 since all multiplex were closed. However, 2021 is proving to be a blockbuster year for the Chinese movie industry as economy has opened. The ticket sale from Chinese movie theatres, which has largely contained the coronavirus, has shown a huge jump. The China multiplex revenue for 2021 is expected to surpass the figures of 2019. According to Renub Research, China Cinema Market is projected to grow with a staggering CAGR of 30.12% from 2020 to 2026.
In China, factors that drive the cinema industries development are increasing the quota of foreign film in China, growth in the number of 3d screens in China, rising disposable incomes, growing number of working populations, rapid technology development in the filmmaking, film-screening equipment manufacturing industries, and the implementation of the cinema circuit system. In future the online movie industry is also expected to emerge as the 'new giant'. As per our research report, the China Film Industry was US$ 3.4 Billion in 2020. China's film industry is on record for accelerated growth over the upcoming years. In the Chinese film industry, various films are created, such as feature film, cartoons, popular science films, documentary films, and special films. Feature Film and Popular Science Films is leading in the China cinema industry as people are interested and are enjoying these in theatres. Additionally, the Cinematic Imports in China maintain tight command over foreign films that are permitted to be screened, potentially pushed by the concern that a completely open market would endanger the local filming industry. Currently, there are two business models for foreign films releasing in China: revenue-sharing and flat-rate (i.e., a buy-out). On the other hand, Joint productions are deemed as domestic films. They can be directly released in the PRC after completing and passing the censorship review. According to our latest report, the China Movie Market is expected to reach US$ 16.5 Billion by 2026. The 1st Tier and 2nd Tier cities in China hold most of the China cinema market due to the availability of more theatres, infrastructure, and people willing to pay higher prices for tickets than 3rd Tier and 4th cities. Ticket rates in these cities are also much higher than in the rest of the cities. The companies acting as the major players in the China Cinemas industry include Dalian Wanda Group, China Film Group Corporation, Guangdong Dadi Cinema Circuit Co. Ltd., Shanghai Film Group Corporation and Hengdian Group Holdings Limited. Effect of COVID-19 on the Chinese Cinema Industry: Revenue for Cinemas in China declined in 2020, as the COVID-19 pandemic has severely restricted film screening activity. But, the demand for film watching is surging in Chinese theatres as they were able to reopen by midyear and have seen continuous audience growth. Lunar Year for 2021 came as a blessing for the Chinese box office, as most people were encouraged to stay in the city. So watching movies in the theatres became the top choice of entertainment. Besides, the lack of other entertainment options helped pump up ticket sales during the pandemic. Renub Research latest report "China Cinema Market by Movies (Domestic (Chinese) Movies, Imported Movies, Exported Movies), Film Production (Feature Film, Cartoons, Popular Science Films, Documentary Films, Special Films), Tier City (1st Tier Cities, 2nd Tier Cities, 3rd Tier Cities, 4th Tier Cities, 5th Tier Cities), Movie Industry (Movie Screens in China, Movie Admission in China), Movie Ticket Pricing Analysis by City, Company (IMAX China Holding, SMI Holdings Group Limited, Huayi Tencent Entertainment Company Limited, Perfect World, Wanda Film Holding Co Ltd)" provides all-encompassing insights of China Cinema Industry. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=china-cinema-market-p.php China Movie Market covered from 3 viewpoints: • Domestic (Chinese) Movies • Imported Movies • Exported Movies China Film Production Volume Analysis covered from 5 viewpoints: • Feature Film • Cartoons • Popular Science Films • Documentary Films • Special Films Tier City - China Movie Market covered from 5 viewpoints: • 1st Tier Cities • 2nd Tier Cities • 3rd Tier Cities • 4th Tier Cities • 5th Tier Cities China Movie Industry Analysis covered from 2 viewpoints: • Movie Screens in China • Movie Admission in China Tier City - China Movie Ticket Pricing Analysis covered from 5 viewpoints: • 1st Tier Cities • 2nd Tier Cities • 3rd Tier Cities • 4th Tier Cities • 5th Tier Cities Company Analysis has been covered from 3 viewpoints: • Overview • Recent Development • Sales Analysis Company Insights: • IMAX China Holding • SMI Holdings Group Limited • Huayi Tencent Entertainment Company Limited • Perfect World • Wanda Film Holding Co Ltd About the Company: Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building and Construction, & Agriculture. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions. Our core team is comprised of experienced people holding graduate, postgraduate and PhD degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets. Contact Us: Renub Research Phone No: +1 678–302–0700 (USA) | +91–120–421–9822 (IND) Email: [email protected] Web: https://www.renub.com Follow on Linkedin: https://www.linkedin.com/company/renub-research |
Archives
November 2021
Categories
All
|